Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Pharm Biomed Anal ; 139: 133-142, 2017 May 30.
Artigo em Inglês | MEDLINE | ID: mdl-28279928

RESUMO

Requisite leachables testing of pharmaceutical products is commonly conducted with pre-defined analytical methods on a subset of materials intended to be representative of the marketed product. Throughout product development, leachables may occasionally be detected in other methods not specifically intended for monitoring such impurities. We have identified two leachables, ethyl 4-ethoxybenzoate (E4E) and 2,6-di(t-butyl)-4-hydroxy-4-methyl-2,5-cyclohexadien-1-one (BHT-OH) in a low concentration product stored in prefilled syringes (PFS). The leachables were initially detected by size exclusion chromatography (SEC) as late-eluting impurity peaks. Syringe component extraction studies indicated that the impurities were related to the syringe stoppers. Positive identification of E4E was accomplished by reversed phase liquid chromatography- tandem mass spectrometry (RPLC-MS/MS). Positive identification of BHT-OH required RPLC-solid phase extraction-cryoflow NMR (RPLC-SPE-NMR), as initial RPLC-MS/MS investigations were unsuccessful in elucidating the structure. We focus specifically on the efforts required to identify the leachables, and the fortuitous mixed mode separation mechanism and low concentration nature of the product, which were the main factors contributing to the unlikely detection of the leachables by SEC. We note that our investigations were conducted independently of formal leachables and extractables (L&E) studies and we discuss challenges with designing and conducting such studies in a manner that captures the comprehensive L&E profile of a product.


Assuntos
Cromatografia em Gel/métodos , Cromatografia de Fase Reversa/métodos , Contaminação de Medicamentos , Embalagem de Medicamentos/instrumentação , Seringas , Espectrometria de Massas em Tandem/métodos , Embalagem de Medicamentos/métodos , Espectroscopia de Ressonância Magnética/métodos
2.
Pharm Dev Technol ; 21(3): 311-20, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-25708152

RESUMO

The impact of pepsin on the maintenance of supersaturated solution of the HCl salt of a weakly basic drug was evaluated in simulated gastric fluid by monitoring the drug solubility in the absence and presence of pepsin. In the presence of pepsin, the HCl salt maintained its apparent solubility through 24 h, whereas, no such solubility advantage was seen in the absence of pepsin. Consequently, a minimum inhibitory concentration of pepsin is required for maintenance of supersaturation. In addition, NMR study seems to indicate a molecular level interaction between pepsin and HCl salt leading to a weak binding between the two. Therefore, for the HCl salts of weak bases having disproportionation potential, it is preferred that preformulation solubility studies are conducted in the presence of pepsin to reflect their in vivo behavior in maintaining supersaturation solubility.


Assuntos
Ácido Clorídrico/química , Pepsina A/química , Soluções Farmacêuticas/química , Química Farmacêutica/métodos , Concentração de Íons de Hidrogênio , Solubilidade
3.
Pharm Res ; 32(8): 2579-94, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25724158

RESUMO

PURPOSE: Precipitation of weakly basic drugs in intestinal fluids can affect oral drug absorption. In this study, the implications of self-association of brivanib alaninate in acidic aqueous solution, leading to supersaturation at basic pH condition, on its solubility and oral absorption were investigated. METHODS: Self-association of brivanib alaninate was investigated by proton NMR spectroscopy, surface tension measurement, dynamic light scattering, isothermal titration calorimetry, and molecular modeling. Drug solubility was determined in various pH media, and its tendency to supersaturate upon pH shift was investigated in buffered and biorelevant aqueous solutions. Pharmacokinetic modeling of human oral drug absorption was utilized for parameter sensitivity analyses of input variables. RESULTS: Brivanib alaninate exhibited continuous, and pH- and concentration-dependent self-association. This phenomenon resulted in positive deviation of drug solubility at acidic pH and the formation of a stable supersaturated drug solution in pH-shift assays. Consistent with the supersaturation phenomenon observed in vitro, oral absorption simulations necessitated invoking long precipitation time in the intestine to successfully predict in vivo data. CONCLUSIONS: Self-association of a weakly basic drug in acidic aqueous solution can increase its oral absorption by supersaturation and precipitation resistance at the intestinal pH. This consideration is important to the selection of parameters for oral absorption simulation.


Assuntos
Alanina/análogos & derivados , Triazinas/química , Triazinas/farmacocinética , Administração Oral , Alanina/química , Alanina/farmacocinética , Soluções Tampão , Calorimetria , Química Farmacêutica , Coloides , Simulação por Computador , Humanos , Concentração de Íons de Hidrogênio , Absorção Intestinal , Espectroscopia de Ressonância Magnética , Modelos Moleculares , Tamanho da Partícula , Solubilidade , Tensão Superficial
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...